In Vitro Activity of Tedizolid, Dalbavancin, and Ceftobiprole Against Clostridium difficile.

about

In Vitro Activity of Tedizolid, Dalbavancin, and Ceftobiprole Against Clostridium difficile.

Item

http://www.wikidata.org/entity/Q55282846

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

In Vitro Activity of Tedizolid ...... Against Clostridium difficile.

@en

In Vitro Activity of Tedizolid ...... Against Clostridium difficile.

@nl

type

Item

label

In Vitro Activity of Tedizolid ...... Against Clostridium difficile.

@en

In Vitro Activity of Tedizolid ...... Against Clostridium difficile.

@nl

prefLabel

In Vitro Activity of Tedizolid ...... Against Clostridium difficile.

@en

In Vitro Activity of Tedizolid ...... Against Clostridium difficile.

@nl

P1476

In Vitro Activity of Tedizolid ...... Against Clostridium difficile

@en

P2093

Avi Peretz

http://www.w3.org/2001/XMLSchema#string

Dana Binyamin

http://www.w3.org/2001/XMLSchema#string

Maya Azrad

http://www.w3.org/2001/XMLSchema#string

Omry Koren

http://www.w3.org/2001/XMLSchema#string

Orna Nitzan

http://www.w3.org/2001/XMLSchema#string

Zohar Hamo

http://www.w3.org/2001/XMLSchema#string

P2860

Disruption of the Gut Microbiome: Clostridium difficile Infection and the Threat of Antibiotic Resistance

Clostridium difficile spore biology: sporulation, germination, and spore structural proteins

Role of cephalosporins in the era of Clostridium difficile infection

Fecal microbiota transplant for relapsing Clostridium difficile infection using a frozen inoculum from unrelated donors: a randomized, open-label, controlled pilot study

Clostridium difficile--more difficult than ever.

Effect of ceftobiprole treatment on growth of and toxin production by Clostridium difficile in cecal contents of mice

In vitro activities of dalbavancin and nine comparator agents against anaerobic gram-positive species and corynebacteria

Analysis of the phase 3 ESTABLISH trials of tedizolid versus linezolid in acute bacterial skin and skin structure infections

Pharmacokinetics and pharmacodynamics of ceftobiprole, an anti-MRSA cephalosporin with broad-spectrum activity.

Antimicrobial-associated risk factors for Clostridium difficile infection.

P304

1256

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FMICB.2018.01256

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-06-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29942295

http://www.w3.org/2001/XMLSchema#string

P921

Clostridium difficile

P932

6004428

http://www.w3.org/2001/XMLSchema#string